Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Market Cap	1.70B
Revenue (ttm)	1.48B
Net Income (ttm)	42.97M
Shares Out	23.66M
EPS (ttm)	1.82
PE Ratio	39.66
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,466
Average Volume	3,396
Open	71.57
Previous Close	75.34
Day's Range	71.57 - 73.00
52-Week Range	69.00 - 104.80
Beta	0.18
RSI	40.24
Earnings Date	May 30, 2025

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 363
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BAFNAPH

Financial Performance

In 2023, Bafna Pharmaceuticals's revenue was 1.52 billion, an increase of 32.18% compared to the previous year's 1.15 billion. Earnings were 73.48 million, a decrease of -35.19%.